Sidoxia Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sidoxia Capital Management's BMY Position: Q2 2026 in Review
Sidoxia Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 2.9% in Q2 2026, selling an estimated $6.66K and leaving 3,925 shares worth $226K. The position accounts for 0.17% of the portfolio, ranked #85.
Sidoxia Capital Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $245K in Q1 2026. 2,503 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Sidoxia Capital Management held 3,925 shares of Bristol-Myers Squibb worth $226K as of Q2 2026.
- Sidoxia Capital Management sold 116 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.66K.
- Bristol-Myers Squibb made up 0.17% of Sidoxia Capital Management's portfolio in Q2 2026, its #85 holding.
- Sidoxia Capital Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Sidoxia Capital Management's Bristol-Myers Squibb position peaked at $245K in Q1 2026.
- 2,503 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Sidoxia Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.